How much does trametinib targeted drug cost?

Trametinib is a targeted drug developed by GlaxoSmithKline (GSK) and was approved by the US FDA on May 29, 2013, under the trade name Mekinist. It is an oral tablet indicated primarily for the treatment of unresectable or metastatic melanoma harboring the BRAF V600E or V600K mutation.

The mechanism of action of trametinib is to inhibitMEK protein kinase, which is a key node in the MAPK signaling pathway. By blocking this signaling pathway, trametinib can inhibit the proliferation and survival of tumor cells. In preclinical and clinical trials, trametinib has shown significant inhibitory effects on BRAF V600 mutation-positive melanoma cells. In addition, trametinib is combined with other drugs such as dabrafenib to further enhance the therapeutic effect.

As a targeted drug, trametinib is highly selective and specific and can reduce damage to normal cells, thereby reducing side effects. However, patients still need to pay attention to possible adverse reactions when using trametinib, such as rash, diarrhea, nausea, etc., and follow the doctor's recommendations for regular monitoring and dose adjustment.

The launch of trametinib provides new treatment options for melanoma patients carryingBRAF V600 mutations and promotes the development of targeted therapy. With the deepening of research and the accumulation of clinical experience, the application prospects of trametinib will be broader.

In China, trametinib has been included in the medical insurance catalog, and patients can conveniently purchase the original drug of 2mg*30 tablets per box. After medical insurance reimbursement, the price is reduced to about 10,000 yuan per box. At the same time, generic trametinib drugs in overseas markets have also attracted much attention, especially the version produced in Laos, which costs only about 1,900 yuan. These generic drugs have won the approval of patients for their affordable prices and good efficacy. For the selection and use of trametinib, we recommend that patients seek professional advice from overseas medical consultants.